Clinical Study
Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
Table 6
Median IOP variation during the follow-up.
| | Median (range) IOP variation (mmHg) | | Screening | 15 days | 1 month | 2 months | 3 months | 6 months |
| | Treatment group | 15 (14–17) | 18 (16–22) | 18 (17–19) | 19 (16–20) | 17 (14–19) | 15 (12–16) | | — | | | | | | | Control group | 14 (14–16) | 15 (14–16) | 14 (14–15) | 17 (16–18) | 16 (16–16) | 15 (14–15) | | — | | | | | | | Comparison between groups | | | | | | |
|
|
